UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 178

Sortiert nach

The Discovery and Development of Liraglutide and Semaglutide

Frontiers in endocrinology (Lausanne), 2019-04, Vol.10, p.155-155

2019

Volltextzugriff (PDF)

Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes

Pharmacological reviews, 2016-10, Vol.68 (4), p.954-1013

2016

Volltextzugriff (PDF)

Structure of the human glucagon class B G-protein-coupled receptor

Nature (London), 2013-07, Vol.499 (7459), p.444-449

2013

Volltextzugriff (PDF)

Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain

The Journal of biological chemistry, 2008-04, Vol.283 (17), p.11340-11347

2008

Volltextzugriff (PDF)

Structure of the full-length glucagon class B G-protein-coupled receptor

Nature (London), 2017-06, Vol.546 (7657), p.259-264

2017

Volltextzugriff (PDF)

Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls

PloS one, 2022-03, Vol.17 (3), p.e0264974-e0264974

2022

Volltextzugriff (PDF)

Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1

European journal of pharmacology, 2016-02, Vol.773, p.24-31

2016

Volltextzugriff (PDF)

214-LB: Activating and Disrupting the Liver–Alpha-Cell Axis Respectively Enhances and Impairs Amino Acid Metabolism and Alpha-Cell Growth

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

1332-P: Increased and Decreased Glucagon Receptor Signaling Respectively Enhances and Impairs Triglyceride Metabolism Acutely and Chronically

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice

Molecular metabolism (Germany), 2022-12, Vol.66, p.101639-101639, Article 101639

2022

Volltextzugriff (PDF)

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells

iScience, 2022-11, Vol.25 (11), p.105296-105296, Article 105296

2022

Volltextzugriff (PDF)

Small-molecule agonists for the glucagon-like peptide 1 receptor

Proceedings of the National Academy of Sciences - PNAS, 2007-01, Vol.104 (3), p.937-942

2007

Volltextzugriff (PDF)

Mucosal absorption of therapeutic peptides by harnessing the endogenous sorting of glycosphingolipids

eLife, 2018-05, Vol.7

2018

Volltextzugriff (PDF)

Editors’ Note: Europe Faces COVID-19

European company and financial law review, 2020-04, Vol.17 (2), p.125-128

2020

Volltextzugriff (PDF)

Identification and in Vivo and in Vitro Characterization of Long Acting and Melanocortin 4 Receptor (MC4-R) Selective α-Melanocyte-Stimulating Hormone (α-MSH) Analogues

Journal of medicinal chemistry, 2012-03, Vol.55 (5), p.1969-1977

2012

Volltextzugriff (PDF)

Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B

Journal of medicinal chemistry, 2002-09, Vol.45 (20), p.4443-4459

2002

Volltextzugriff (PDF)

Ureas with histamine H3-antagonist receptor activity : A new scaffold discovered by lead-hopping from cinnamic acid amides

Bioorganic & medicinal chemistry letters, 2006-10, Vol.16 (20), p.5303-5308

2006

Volltextzugriff (PDF)

Discovery of the Once-Weekly Glucagon-Like Peptide‑1 (GLP-1) Analogue Semaglutide

Journal of medicinal chemistry, 2015-09, Vol.58 (18), p.7370-7380

2015

Volltextzugriff (PDF)

Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy

Current pharmaceutical design, 2001-09, Vol.7 (14), p.1451

2001

Volltextzugriff (PDF)

Editors’ Note: Companies without Legal Capital and the Strange Case of Denmark

European company and financial law review, 2019-12, Vol.16 (6), p.677-686

Hansen, Jesper Lau

2019

Volltextzugriff (PDF)

Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators

Nature (London), 2017-06, Vol.546 (7657), p.312-315

2017

Volltextzugriff (PDF)

Structure of the glucagon receptor in complex with a glucagon analogue

Nature (London), 2018-01, Vol.553 (7686), p.106-110

2018

Volltextzugriff (PDF)

Investigation into reversed phase chromatography peptide separation systems part I: Development of a protocol for column characterisation

Journal of Chromatography A, 2019-10, Vol.1603, p.113-129

2019

Volltextzugriff (PDF)

The MAD disclosure regime and the twofold notion of inside information: the available solution

Capital markets law journal, 2009-07, Vol.4 (3), p.323-340

2009

Volltextzugriff (PDF)

Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide

Journal of medicinal chemistry, 2002-12, Vol.45 (26), p.5755-5775

2002

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Discovery and Development of Liraglutide and Semaglutide

Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes

Structure of the human glucagon class B G-protein-coupled receptor

Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain

Structure of the full-length glucagon class B G-protein-coupled receptor

Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls

Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1

214-LB: Activating and Disrupting the Liver–Alpha-Cell Axis Respectively Enhances and Impairs Amino Acid Metabolism and Alpha-Cell Growth

1332-P: Increased and Decreased Glucagon Receptor Signaling Respectively Enhances and Impairs Triglyceride Metabolism Acutely and Chronically

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells

Small-molecule agonists for the glucagon-like peptide 1 receptor

Mucosal absorption of therapeutic peptides by harnessing the endogenous sorting of glycosphingolipids

Editors’ Note: Europe Faces COVID-19

Identification and in Vivo and in Vitro Characterization of Long Acting and Melanocortin 4 Receptor (MC4-R) Selective α-Melanocyte-Stimulating Hormone (α-MSH) Analogues

Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B

Ureas with histamine H3-antagonist receptor activity : A new scaffold discovered by lead-hopping from cinnamic acid amides

Discovery of the Once-Weekly Glucagon-Like Peptide‑1 (GLP-1) Analogue Semaglutide

Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy

Editors’ Note: Companies without Legal Capital and the Strange Case of Denmark

Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators

Structure of the glucagon receptor in complex with a glucagon analogue

Investigation into reversed phase chromatography peptide separation systems part I: Development of a protocol for column characterisation

The MAD disclosure regime and the twofold notion of inside information: the available solution

Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide

Suchergebnisse filtern